INFU (InfuSystem Holdings, Inc.) Stock Analysis - Analyst Ratings

InfuSystem Holdings, Inc. (INFU) is a publicly traded Healthcare sector company. As of May 21, 2026, INFU trades at $10.01 with a market cap of $179.62M and a P/E ratio of 26.47. INFU moved +5.38% today. Year to date, INFU is +15.19%; over the trailing twelve months it is +66.56%. Its 52-week range spans $4.61 to $11.04. Analyst consensus is strong buy with an average price target of $15.83. Rallies surfaces INFU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate INFU?

3 analysts cover INFU: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $15.83.

INFU Key Metrics

Key financial metrics for INFU
MetricValue
Price$10.01
Market Cap$179.62M
P/E Ratio26.47
EPS$0.38
Dividend Yield0.00%
52-Week High$11.04
52-Week Low$4.61
Volume0
Avg Volume0
Revenue (TTM)$142.40M
Net Income$7.91M
Gross Margin56.75%

INFU Analyst Consensus

3 analysts cover INFU: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.83.

Latest INFU News

Recent INFU Insider Trades

  • Lachance Carrie bought 1.00K (~$8.46K) on May 11, 2026.
  • GENDRON PAUL ANDREW bought 5.00K (~$44.40K) on May 8, 2026.
  • Lachance Carrie bought 2.00K (~$17.66K) on May 8, 2026.

Common questions about INFU

What do analysts rate INFU?
3 analysts cover INFU: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $15.83.
Does Rallies show INFU price targets?
Yes. Rallies tracks INFU analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is INFU research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INFU. It does not provide personalized investment advice.
INFU

INFU